The United Laboratories International Holdings Limited (FRA:UNJ)

Germany flag Germany · Delayed Price · Currency is EUR
1.100
+0.040 (3.77%)
At close: Mar 27, 2026
Market Cap2.22B -29.2%
Revenue (ttm)1.61B -4.0%
Net Income254.00M -21.6%
EPS0.13 -24.4%
Shares Outn/a
PE Ratio8.74
Forward PE11.00
Dividend0.07 (6.07%)
Ex-Dividend DateSep 25, 2025
Volumen/a
Average Volume329
Open1.100
Previous Close1.060
Day's Range1.100 - 1.100
52-Week Range1.060 - 1.870
Betan/a
RSI36.96
Earnings DateMar 24, 2026

About FRA:UNJ

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin... [Read more]

Industry Pharmaceutical Preparations
Founded 1990
Employees 17,400
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol UNJ

Financial Performance

In 2025, FRA:UNJ's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY Financial Statements